Imazodan

This classification denotes a phosphodiesterase inhibitor with the molecular formula C13H12N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 6PVQ5VQW24 chemically known as 3(2h)-pyridazinone, 4,5-dihydro-6-(4-(1h-imidazol-1-yl)phenyl) but generally known as imazodan, which bears US NIH Compound Identifier 55918. European Medicines Agency schedules Imazodan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08139MIG. The term IMAZODAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26). Most nations schedule imazodan under HS 29332990 and SITC 51573. As of Q4 2014, IMAZODAN remains the US FDA Preferred Term for this commodity. Imazodan bears US NLM identifiers UMLS ID C0055686 and NCI Concept Code C83787. SMILES: C1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3.